Wellington Management Group LLP Ayala Pharmaceuticals, Inc. Transaction History

Wellington Management Group LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.99 - $4.15 $642,166 - $2.69 Million	-648,653 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.5 - $9.11 $215,537 - $561,012	-61,582 Reduced 8.67%	648,653 $2.58 Million
Q4 2021 Feb 11, 2022	SELL	$8.32 - $12.45 $2.09 Million - $3.13 Million	-251,374 Reduced 26.14%	710,235 $6.04 Million
Q3 2021 Nov 15, 2021	BUY	$8.13 - $14.09 $2.09 Million - $3.62 Million	257,246 Added 36.52%	961,609 $10.9 Million
Q2 2021 Aug 16, 2021	SELL	$9.2 - $11.3 $43,102 - $52,940	-4,685 Reduced 0.66%	704,363 $7.18 Million
Q1 2021 May 17, 2021	SELL	$10.72 - $22.0 $496,411 - $1.02 Million	-46,307 Reduced 6.13%	709,048 $7.74 Million
Q4 2020 Feb 12, 2021	SELL	$9.67 - $13.5 $44,269 - $61,803	-4,578 Reduced 0.6%	755,355 $8.6 Million
Q3 2020 Nov 16, 2020	SELL	$8.8 - $14.55 $494,296 - $817,273	-56,170 Reduced 6.88%	759,933 $8.95 Million
Q2 2020 Aug 14, 2020	BUY	$10.0 - $15.92 $8.16 Million - $13 Million	816,103 New	816,103 $8.19 Million

Ticker AYLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,833,300
Description
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

Stay updated on Wellington Management Group LLP with notifications on news.